Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wakefield

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Molecular Therapy. Nucleic Acids|October 9, 2024
<i>RAB18</i> regulates extrahepatic siRNA-mediated gene silencing efficacyJiamiao Lu, Jasper Lee, Eric Yuan, et al.
Stem Cell Reports|December 16, 2022
Titin-truncating variants in hiPSC cardiomyocytes induce pathogenic proteinopathy and sarcomere defects with preserved core contractile machineryGuanyi Huang, Anjali Bisaria, Devin L Wakefield, et al.
Molecular Pharmaceutics|January 16, 2026
Nonspecific Cellular Interactions Are a Key Determinant in the Disposition of Fc-Fused ProteinsMark A Bryniarski, Songyu Wang, Aochiu Chen, et al.
Science (New York, N.Y.)|January 29, 2026
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapyJunedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Molecular Therapy. Nucleic Acids|October 9, 2024
<i>RAB18</i> regulates extrahepatic siRNA-mediated gene silencing efficacyJiamiao Lu, Jasper Lee, Eric Yuan, et al.
Stem Cell Reports|December 16, 2022
Titin-truncating variants in hiPSC cardiomyocytes induce pathogenic proteinopathy and sarcomere defects with preserved core contractile machineryGuanyi Huang, Anjali Bisaria, Devin L Wakefield, et al.
Molecular Pharmaceutics|January 16, 2026
Nonspecific Cellular Interactions Are a Key Determinant in the Disposition of Fc-Fused ProteinsMark A Bryniarski, Songyu Wang, Aochiu Chen, et al.
Science (New York, N.Y.)|January 29, 2026
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapyJunedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, et al.
Pageof 9